Annual Biomarker Congress

At the 15^th Annual Biomarkers Congress, over 350 attendees will be representing global pharmaceutical organizations, leading biotech and diagnostic companies as well as internationally renowned academic and healthcare institutions working in the biomarker space across multiple therapeutic areas, such as immuno-oncology, neuroscience and cardiology. The event will feature over 100 presentations, workshops, roundtables and panel discussions focusing on the key opportunities and challenges in biomarker research, from precision medicine and diagnostics through to preclinical and clinical research. The conference will feature the following interactive streams:

• Biomarkers in drug discovery & development – therapeutic areas: oncology, immuno-oncology and immunology
• Biomarkers in drug discovery & development – therapeutic areas: neuroscience, cardiovascular disorders and rare disease
• Biomarkers for detection, monitoring & diagnosis
• New biomarker technologies & data
• Biomarkers for clinical development
• Biomarkers for preclinical development

Interested in biomarker research? Why not check out…

LBA for biomarker validation: an interview with Joel Mathews

Biomarker validation and flow cytometry: an interview with Rafiq Islam

2018 White Paper on Recent Issues in Bioanalysis: ‘A global bioanalytical community perspective on last decade of incurred samples reanalysis (ISR)’ (Part 1 – small molecule regulated bioanalysis, small molecule biomarkers, peptides & oligonucleotide bioanalysis)